p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. - sprookjes - yvandenbroek - TriplyDB

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

http://www.wikidata.org/entity/Q34593224

about

Oral adsorbents for preventing or delaying the progression of chronic kidney disease Gut Microbiome and Kidney Disease in Pediatrics: Does Connection Exist?Gut Bacteria and Hydrogen Sulfide: The New Old Players in Circulatory System Homeostasis Indoxyl Sulfate-Review of Toxicity and Therapeutic Strategies Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Gut microbiome and kidney disease: a bidirectional relationship.Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.Dietary Metabolites and Chronic Kidney Disease.Heritability and clinical determinants of serum indoxyl sulfate and p-cresyl sulfate, candidate biomarkers of the human microbiome enterotype Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.Alteration of the gut microbiota in Chinese population with chronic kidney disease Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease.SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition.Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites.The colon: an overlooked site for therapeutics in dialysis patients.An update on uremic toxins.Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?Association of indoxyl sulfate with heart failure among patients on hemodialysis.Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients.The gut microbiome, kidney disease, and targeted interventions.Increased levels of total P-Cresylsulphate and indoxyl sulphate are associated with coronary artery disease in patients with diabetic nephropathy Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.A study of the effects of exercise on the urinary metabolome using normalisation to individual metabolic output.Uremic retention solute indoxyl sulfate level is associated with prolonged QTc interval in early CKD patients Thrombosis in the uremic milieu--emerging role of "thrombolome".A pharmaco-metabonomic study on chronic kidney disease and therapeutic effect of ergone by UPLC-QTOF/HDMS Systems biology of host-microbe metabolomics.Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.The Role of Liver in Determining Serum Colon-Derived Uremic Solutes.Gut microbiome in chronic kidney disease.The Influence of CKD on Colonic Microbial Metabolism.Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation.Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD.

P2860

Q24193105-CD48414F-C609-4949-8A6B-AB624061D33D Q26765943-EAE40D95-9864-436F-B6FC-791A9BFDA90A Q28066350-510C6806-BD71-46A2-93D4-BBF49F0F383F Q28075033-2A22FB7A-EC19-4B84-B174-244F1CBCA424 Q30235846-FD28CDD4-4058-41AC-A96A-9B676625FC19 Q33586234-26784880-E73B-44A2-8A32-F67B8B550F06 Q33613115-5F03CB9B-3C7C-4C96-B835-04F489F5E2BC Q33616732-90C0BD8F-7909-46E1-B9B6-D4C88694BA99 Q33644514-21413A6B-6704-4ECF-9852-027938D56A6A Q33749467-D7E2CCF9-F472-4AE2-B124-BA6615B826CE Q33767631-D01ED659-D980-4393-877C-614919FEECB0 Q33780255-E63A5E3A-63D1-4DFA-93FA-3F489C88C4E9 Q33890104-15A1E364-2B13-4ECB-AAF0-796CB79F903A Q34043268-C22F16FB-51E9-4547-B67B-8BFDEA28987F Q34103477-FDAAC8F5-B879-4B1E-9714-631D45FC4F16 Q34221944-B0972141-FB98-41DD-9041-F62849B55B1F Q34484986-05506C22-8CA5-4480-952D-DE189FC4F55F Q34498094-B4A31DCE-4273-4AC2-A427-EA80373F6678 Q34607428-00681A39-C338-4401-AF47-953751B144B6 Q34641464-21E9D53A-33A1-4EB5-81C2-9E0E10B12B39 Q34796627-C37F74BF-E837-41C5-91CE-A3AF824D464B Q34828638-6CBC984A-A91F-43FF-B6B5-45F14EABEAF7 Q34995574-2A05BD65-DACF-43C8-A606-41351D794135 Q35042986-6BC6D599-2056-4808-BDFE-21CBF3F251BD Q35127942-781FA204-F820-4EA4-B808-B0B7094F88D1 Q35156688-92521402-F06A-422F-BCEF-8D87086AD345 Q35237607-1D70251E-6429-41FC-8D31-8D8F3B0D70C9 Q35495467-8C6B9831-DE3A-4162-854D-80B68B900ADA Q35532702-68C363B1-A3BA-400E-9B79-DCA54CE5AFB3 Q35533024-E1182327-7234-4FE4-931B-A25D5BBC4ECC Q35619563-155884DD-1C1B-4920-9BE1-FC48AE8D9B20 Q35737363-44A602DC-A1BC-478F-A299-0013997BAF80 Q35741260-21CD2CFD-EFA3-4F99-A7BD-C9781164B348 Q35764101-2DFC31D0-E44D-4A67-942D-65751AC56C9D Q35786047-CABA6623-1497-4112-962C-1A873E84B7E1 Q35790521-58C4F126-38AB-4AA7-AB08-8F4474ECC063 Q35835293-9A29DF67-34FF-4F4B-91E0-33A643FAC012 Q35891553-BA208F0F-1D6C-426C-94DF-B1F85663DB01 Q35995858-B9052C27-8472-4EFF-B613-4FAB4ED17C9B Q36031714-1156431A-2455-43ED-9F94-73C981B5FCC4

P2860

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

http://www.wikidata.org/entity/Q34593224

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

@ast

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

@en

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

@nl

type

label

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

@ast

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

@en

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

@nl

prefLabel

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

@ast

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

@en

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

@nl

P1433

Q34593224-70358A0F-A140-4D60-A158-6A9D1A2706AA

P1476

Q34593224-DE047CCA-1B25-48E7-912C-D44AF011A9FF

P2093

Q34593224-04B4143C-FA12-4F4C-BFE0-4FCE2AF181BE

Q34593224-187B1EC2-518F-4698-839C-9C21187C8719

Q34593224-4010F066-338F-4DBF-9D74-C1AFE450A833

Q34593224-5B4E5482-E578-4C84-A91C-21D2561618EB

Q34593224-6EC3662D-64DE-48D2-992D-7E380D184AEC

Q34593224-6EDF63A4-AF5E-4082-A45E-2AAF7B67443C

Q34593224-882D5905-D41F-4EC5-835B-A9DB931488BC

Q34593224-BA0048C3-8EA9-42DE-9CEF-3E80DFCA9515

Q34593224-C4DA676E-E06E-4977-B06C-B1EA802A497F

Q34593224-E04243B7-C3DA-406A-8C45-69D442FAB464

P2860

Q34593224-001D280D-DF4E-4E04-A258-2F3EA655E0AE

Q34593224-020F6AF5-253C-44A0-B5AF-C629A92E66E8

Q34593224-0B8EEE69-EE99-4962-B796-F32A81F0F9BA

Q34593224-10884B99-8BF3-4C98-90A0-E0FA289DB1CE

Q34593224-286393C1-FD97-4402-A5D6-ECE7FF1F6E1C

Q34593224-2912D9BF-AD79-4956-BA24-F3A1442C6010

Q34593224-306F1F3F-9223-4123-8A63-EFEDFCCB8DD9

Q34593224-358C8812-DD04-4F27-AC05-A15D71D90856

Q34593224-36A61AE1-8C3B-4497-AF9F-4EF3DF5D38C0

Q34593224-3EEE59AF-B728-45E1-80D8-C8D5DA1B4C40

P304

Q34593224-103FD003-1A30-4D56-B119-534138DFBCB8

P31

Q34593224-C443561B-FCDE-454F-98E7-89006294724B

P356

Q34593224-CDB5E885-4E24-46A0-A422-A7775D8C1D97

P407

Q34593224-54213BF9-37DC-4B23-A50D-4A7A04B119EE

P433

Q34593224-8E7ADEB0-8676-44B8-889A-FEC65601C827

P478

Q34593224-A1242A5E-0BFB-4C0A-A68C-6C29BF1EC197

P577

Q34593224-55C89676-7D98-447B-9D8C-EA70D957B600

P5875

Q34593224-7204E187-B8BB-4B68-811F-6517F1F40B78

P698

Q34593224-2414966A-2EC9-43EA-95A2-E1860FD96DCE

P932

Q34593224-AE068B0B-FF1F-4509-A861-1E13C95D1CE7

P356

P1433

Nephrology Dialysis Transplantation

P1476

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

@en

P2093

Chi-Jen Tsai

http://www.w3.org/2001/XMLSchema#string

Chiao-Yin Sun

http://www.w3.org/2001/XMLSchema#string

Chin-Chan Lee

http://www.w3.org/2001/XMLSchema#string

Chin-Yuan Tzen

http://www.w3.org/2001/XMLSchema#string

Ching-Yuang Lin

http://www.w3.org/2001/XMLSchema#string

Heng-Jung Hsu

http://www.w3.org/2001/XMLSchema#string

I-Wen Wu

http://www.w3.org/2001/XMLSchema#string

Kuang-Hung Hsu

http://www.w3.org/2001/XMLSchema#string

Mai-Szu Wu

http://www.w3.org/2001/XMLSchema#string

Yen-Chih Wang

http://www.w3.org/2001/XMLSchema#string

P2860

p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

p-Cresol and cardiovascular risk in mild-to-moderate kidney disease

New insights into uremic toxicity.

Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study.

Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients.

Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis.

Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease.

ROS and PDGF-beta [corrected] receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration.

P304

938-947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFQ580

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47156292

http://www.w3.org/2001/XMLSchema#string

P698

20884620

http://www.w3.org/2001/XMLSchema#string

P932

3042976

http://www.w3.org/2001/XMLSchema#string